Subcutaneous Needle-free Injectors - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Medical Devices & Consumables > Subcutaneous Needle-free Injectors - Global Top Players Market Share and Ranking 2025

Subcutaneous Needle-free Injectors - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-23
Report Id: 2809358
Industry: Medical Devices & Consumables
Report Page: 118
Chart: 112

PDF Download

Publication Date: 2025-11-23
Report Id: 2809358
Industry: Medical Devices & Consumables
Report Page: 118
Chart: 112

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Subcutaneous Needle-free Injectors Definition
1.2 Global Subcutaneous Needle-free Injectors Market Size and Forecast
1.2.1 By Consumption Value, Global Subcutaneous Needle-free Injectors Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Subcutaneous Needle-free Injectors Market Size, 2020-2031
1.2.3 Global Subcutaneous Needle-free Injectors Average Selling Price (ASP), 2020-2031
1.3 China Subcutaneous Needle-free Injectors Market Size and Forecast
1.3.1 By Consumption Value, China Subcutaneous Needle-free Injectors Market Size, 2020-2031
1.3.2 By Sales Quantity, China Subcutaneous Needle-free Injectors Market Size, 2020-2031
1.3.3 China Subcutaneous Needle-free Injectors Average Selling Price (ASP), 2020-2031
1.4 Share of China Subcutaneous Needle-free Injectors Market with Respect to the Global Market
1.4.1 By Consumption Value, China Subcutaneous Needle-free Injectors Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Subcutaneous Needle-free Injectors Market Share in Global, 2020-2031
1.4.3 Subcutaneous Needle-free Injectors Market Size: China VS Global, 2020-2031
1.5 Subcutaneous Needle-free Injectors Market Dynamics
1.5.1 Subcutaneous Needle-free Injectors Market Drivers
1.5.2 Subcutaneous Needle-free Injectors Market Restraints
1.5.3 Subcutaneous Needle-free Injectors Industry Trends
1.5.4 Subcutaneous Needle-free Injectors Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Subcutaneous Needle-free Injectors, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Subcutaneous Needle-free Injectors, Global Market Share by Company, 2020-2025
2.3 Subcutaneous Needle-free Injectors Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Subcutaneous Needle-free Injectors Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Subcutaneous Needle-free Injectors Concentration Ratio
2.6 Global Subcutaneous Needle-free Injectors Mergers & Acquisitions, Expansion Plans
2.7 Global Subcutaneous Needle-free Injectors Manufacturers Product Type
2.8 Head Office and Subcutaneous Needle-free Injectors Production Site of Key Manufacturer
2.9 Subcutaneous Needle-free Injectors Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Subcutaneous Needle-free Injectors, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Subcutaneous Needle-free Injectors, China Market Share by Company, 2020-2025
3.3 China Subcutaneous Needle-free Injectors Subcutaneous Needle-free Injectors Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Subcutaneous Needle-free Injectors Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Subcutaneous Needle-free Injectors Capacity by Region
4.3 Global Subcutaneous Needle-free Injectors Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Subcutaneous Needle-free Injectors Production by Region, 2020-2031
4.5 Global Subcutaneous Needle-free Injectors Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Subcutaneous Needle-free Injectors Industry Chain
5.2 Subcutaneous Needle-free Injectors Upstream Analysis
5.2.1 Subcutaneous Needle-free Injectors Core Raw Materials
5.2.2 Main Manufacturers of Subcutaneous Needle-free Injectors Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Subcutaneous Needle-free Injectors Production Mode
5.6 Subcutaneous Needle-free Injectors Procurement Model
5.7 Subcutaneous Needle-free Injectors Industry Sales Model and Sales Channels
5.7.1 Subcutaneous Needle-free Injectors Sales Model
5.7.2 Subcutaneous Needle-free Injectors Typical Distributors

6 Sights by Type
6.1 Subcutaneous Needle-free Injectors Classification by Type
6.1.1 Gas-Driven
6.1.2 Spring-Driven
6.1.3 Electric-Driven
6.1.4 Manual-Driven
6.2 by Type, Global Subcutaneous Needle-free Injectors Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
6.4 by Type, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
6.5 by Type, Global Subcutaneous Needle-free Injectors Average Selling Price (ASP), 2020-2031

7 Sights by Injection Depth
7.1 Subcutaneous Needle-free Injectors Classification by Injection Depth
7.1.1 Intradermal Injector
7.1.2 Subcutaneous Injector
7.1.3 Intramuscular Injector
7.2 by Injection Depth, Global Subcutaneous Needle-free Injectors Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Injection Depth, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
7.4 by Injection Depth, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
7.5 by Injection Depth, Global Subcutaneous Needle-free Injectors Average Selling Price (ASP), 2020-2031

8 Sights by Usage Scenario
8.1 Subcutaneous Needle-free Injectors Classification by Usage Scenario
8.1.1 Clinical Medical Injector
8.1.2 Household Vaccination Injector
8.1.3 Veterinary Injector
8.2 by Usage Scenario, Global Subcutaneous Needle-free Injectors Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Usage Scenario, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
8.4 by Usage Scenario, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
8.5 by Usage Scenario, Global Subcutaneous Needle-free Injectors Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Subcutaneous Needle-free Injectors Segment by Application
9.1.1 Hospitals
9.1.2 Clinics
9.1.3 Home Care Settings
9.1.4 Others
9.2 by Application, Global Subcutaneous Needle-free Injectors Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
9.4 by Application, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
9.5 by Application, Global Subcutaneous Needle-free Injectors Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Subcutaneous Needle-free Injectors Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
10.3 By Region, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Subcutaneous Needle-free Injectors Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Subcutaneous Needle-free Injectors Market Size Market Share
10.5 Europe
10.5.1 Europe Subcutaneous Needle-free Injectors Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Subcutaneous Needle-free Injectors Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Subcutaneous Needle-free Injectors Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Subcutaneous Needle-free Injectors Market Size Market Share
10.7 South America
10.7.1 South America Subcutaneous Needle-free Injectors Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Subcutaneous Needle-free Injectors Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Subcutaneous Needle-free Injectors Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Subcutaneous Needle-free Injectors Consumption Value, 2020-2031
11.3 By Country, Global Subcutaneous Needle-free Injectors Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.4.2 by Type, United States Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.5.2 by Type, Europe Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.6.2 by Type, China Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.7.2 by Type, Japan Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.8.2 by Type, South Korea Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.10.2 by Type, India Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Subcutaneous Needle-free Injectors Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Subcutaneous Needle-free Injectors Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 PharmaJet.
12.1.1 PharmaJet. Company Information, Head Office, Market Area, and Industry Position
12.1.2 PharmaJet. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.1.3 PharmaJet. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 PharmaJet. Company Profile and Main Business
12.1.5 PharmaJet. Recent Developments
12.2 Wirthwein Medical GmbH & Co KG
12.2.1 Wirthwein Medical GmbH & Co KG Company Information, Head Office, Market Area, and Industry Position
12.2.2 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.2.3 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Wirthwein Medical GmbH & Co KG Company Profile and Main Business
12.2.5 Wirthwein Medical GmbH & Co KG Recent Developments
12.3 IntegriMedical Pvt Ltd.
12.3.1 IntegriMedical Pvt Ltd. Company Information, Head Office, Market Area, and Industry Position
12.3.2 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.3.3 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 IntegriMedical Pvt Ltd. Company Profile and Main Business
12.3.5 IntegriMedical Pvt Ltd. Recent Developments
12.4 CROSSJECT
12.4.1 CROSSJECT Company Information, Head Office, Market Area, and Industry Position
12.4.2 CROSSJECT Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.4.3 CROSSJECT Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 CROSSJECT Company Profile and Main Business
12.4.5 CROSSJECT Recent Developments
12.5 MIKA MEDICAL CO.
12.5.1 MIKA MEDICAL CO. Company Information, Head Office, Market Area, and Industry Position
12.5.2 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.5.3 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 MIKA MEDICAL CO. Company Profile and Main Business
12.5.5 MIKA MEDICAL CO. Recent Developments
12.6 Daicel Corporation
12.6.1 Daicel Corporation Company Information, Head Office, Market Area, and Industry Position
12.6.2 Daicel Corporation Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.6.3 Daicel Corporation Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Daicel Corporation Company Profile and Main Business
12.6.5 Daicel Corporation Recent Developments
12.7 NuGen Medical Devices
12.7.1 NuGen Medical Devices Company Information, Head Office, Market Area, and Industry Position
12.7.2 NuGen Medical Devices Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.7.3 NuGen Medical Devices Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 NuGen Medical Devices Company Profile and Main Business
12.7.5 NuGen Medical Devices Recent Developments
12.8 Portal Instruments, Inc.
12.8.1 Portal Instruments, Inc. Company Information, Head Office, Market Area, and Industry Position
12.8.2 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.8.3 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Portal Instruments, Inc. Company Profile and Main Business
12.8.5 Portal Instruments, Inc. Recent Developments
12.9 Covestro AG
12.9.1 Covestro AG Company Information, Head Office, Market Area, and Industry Position
12.9.2 Covestro AG Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.9.3 Covestro AG Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Covestro AG Company Profile and Main Business
12.9.5 Covestro AG Recent Developments
12.10 HealthD
12.10.1 HealthD Company Information, Head Office, Market Area, and Industry Position
12.10.2 HealthD Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.10.3 HealthD Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 HealthD Company Profile and Main Business
12.10.5 HealthD Recent Developments
12.11 Medical International Technologies (MIT Canada) Inc.
12.11.1 Medical International Technologies (MIT Canada) Inc. Company Information, Head Office, Market Area, and Industry Position
12.11.2 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.11.3 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Medical International Technologies (MIT Canada) Inc. Company Profile and Main Business
12.11.5 Medical International Technologies (MIT Canada) Inc. Recent Developments
12.12 Ferring B.V.
12.12.1 Ferring B.V. Company Information, Head Office, Market Area, and Industry Position
12.12.2 Ferring B.V. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.12.3 Ferring B.V. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Ferring B.V. Company Profile and Main Business
12.12.5 Ferring B.V. Recent Developments
12.13 QUINOVARE & TECHiJET.
12.13.1 QUINOVARE & TECHiJET. Company Information, Head Office, Market Area, and Industry Position
12.13.2 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.13.3 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 QUINOVARE & TECHiJET. Company Profile and Main Business
12.13.5 QUINOVARE & TECHiJET. Recent Developments
12.14 Beijing QS Medical Technology Co.Ltd
12.14.1 Beijing QS Medical Technology Co.Ltd Company Information, Head Office, Market Area, and Industry Position
12.14.2 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Models, Specifications, and Application
12.14.3 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Beijing QS Medical Technology Co.Ltd Company Profile and Main Business
12.14.5 Beijing QS Medical Technology Co.Ltd Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Subcutaneous Needle-free Injectors should grow from US$ 872 million in 2024 to US$ 1663 million by 2031, with a CAGR of 9.6% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Subcutaneous Needle-free Injectors

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2024, global Subcutaneous Needle-free Injector production reached approximately 6,406,250 units, with an average global market price of around US$ 128 per unit.

The gross profit margin of major companies in the industry is between 48% – 70%.

Single-line production capacity is 300,000 – 850,000 units/year.

Subcutaneous needle-free injectors are medical devices that deliver drugs through high-pressure jet technology without using traditional needles. They improve patient comfort, reduce needle-stick risks, and enhance compliance in vaccines, diabetes care, biologics delivery, and self-injection scenarios.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Subcutaneous Needle-free Injectors market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Subcutaneous Needle-free Injectors market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Hospitals grew percent to account for percent of the total market sales, and Clinics grew percent.

This report studies and analyses global Subcutaneous Needle-free Injectors status and future trends, helps the client to determine the Subcutaneous Needle-free Injectors market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Subcutaneous Needle-free Injectors, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Subcutaneous Needle-free Injectors market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Units)
(2) Global Subcutaneous Needle-free Injectors sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Units)
(3) China Subcutaneous Needle-free Injectors sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Units)
(4) Global Subcutaneous Needle-free Injectors key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Subcutaneous Needle-free Injectors key producing regions, capacity, production, and year over year growth
(6) Subcutaneous Needle-free Injectors industry chains, upstream, midstream and downstream
Market segment by players, this report covers
PharmaJet.
Wirthwein Medical GmbH & Co KG
IntegriMedical Pvt Ltd.
CROSSJECT
MIKA MEDICAL CO.
Daicel Corporation
NuGen Medical Devices
Portal Instruments, Inc.
Covestro AG
HealthD
Medical International Technologies (MIT Canada) Inc.
Ferring B.V.
QUINOVARE & TECHiJET.
Beijing QS Medical Technology Co.Ltd

Market segment by Type, covers
Gas-Driven
Spring-Driven
Electric-Driven
Manual-Driven

Market segment by Injection Depth, covers
Intradermal Injector
Subcutaneous Injector
Intramuscular Injector

Market segment by Usage Scenario, covers
Clinical Medical Injector
Household Vaccination Injector
Veterinary Injector

Market segment by Application, can be divided into
Hospitals
Clinics
Home Care Settings
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Subcutaneous Needle-free Injectors product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Subcutaneous Needle-free Injectors market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Subcutaneous Needle-free Injectors market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Subcutaneous Needle-free Injectors, percent & CAGR, 2020-2031
Chapter 5: Subcutaneous Needle-free Injectors industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.